127 related articles for article (PubMed ID: 2405592)
1. Minimizing the side effects of glucocorticoid therapy.
Baxter JD
Adv Intern Med; 1990; 35():173-93. PubMed ID: 2405592
[No Abstract] [Full Text] [Related]
2. [New developments in glucocorticoid therapy: selective glucocorticoid receptor agonists, nitrosteroids and liposomal glucocorticoids].
Huisman AM; Jacobs JW; Buttgereit F; Bijlsma JW
Ned Tijdschr Geneeskd; 2006 Mar; 150(9):476-80. PubMed ID: 16553045
[TBL] [Abstract][Full Text] [Related]
3. [New developments in glucocorticoid therapy: selective glucocorticoid receptor agonists, nitrosteroids and liposomal glucocorticoids].
Spijker AJ
Ned Tijdschr Geneeskd; 2006 May; 150(21):1205; author reply 1205. PubMed ID: 16768287
[No Abstract] [Full Text] [Related]
4. Antiinflammatory action of glucocorticoids--new mechanisms for old drugs.
Rhen T; Cidlowski JA
N Engl J Med; 2005 Oct; 353(16):1711-23. PubMed ID: 16236742
[No Abstract] [Full Text] [Related]
5. Preventive techniques to limit glucocorticoid-induced side effects.
Vittorio CC; Werth VP
Adv Dermatol; 2000; 16():273-97; discussion 298. PubMed ID: 11094631
[No Abstract] [Full Text] [Related]
6. [Glucocorticoid therapy in childhood].
Butenandt O
Fortschr Med; 1991 Aug; 109(23):455-9. PubMed ID: 1916578
[TBL] [Abstract][Full Text] [Related]
7. Dissociated glucocorticoid receptor ligands.
Schäcke H; Rehwinkel H
Curr Opin Investig Drugs; 2004 May; 5(5):524-8. PubMed ID: 15202726
[TBL] [Abstract][Full Text] [Related]
8. Glucocorticoid therapy: minimizing side effects.
Longui CA
J Pediatr (Rio J); 2007 Nov; 83(5 Suppl):S163-77. PubMed ID: 18000630
[TBL] [Abstract][Full Text] [Related]
9. [Bronchial asthma and inflammatory dermatoses. Topical glucocorticoid treatment].
Schäfer-Korting M; Korting HC
Pharm Unserer Zeit; 2003; 32(4):306-13. PubMed ID: 12899068
[No Abstract] [Full Text] [Related]
10. Letter: Pustular dermatosis on withdrawal of topically applied steroids.
Stegman SJ
Arch Dermatol; 1974 Jan; 109(1):100. PubMed ID: 4271968
[No Abstract] [Full Text] [Related]
11. Genomic and nongenomic effects of glucocorticoids.
Stahn C; Buttgereit F
Nat Clin Pract Rheumatol; 2008 Oct; 4(10):525-33. PubMed ID: 18762788
[TBL] [Abstract][Full Text] [Related]
12. Therapeutic issues in oral glucocorticoid use.
Bello CE; Garrett SD
Lippincotts Prim Care Pract; 1999; 3(3):333-41; quiz 342-4. PubMed ID: 10711134
[TBL] [Abstract][Full Text] [Related]
13. Current issues of basic and clinical glucocorticoid research.
Buttgereit F
Clin Exp Rheumatol; 2003; 21(2):145-7. PubMed ID: 12747266
[No Abstract] [Full Text] [Related]
14. [Allergic rhinitis. Topical steroids without systemic effect].
Maegele M
Med Monatsschr Pharm; 1999 Mar; 22(3):89-90. PubMed ID: 10223869
[No Abstract] [Full Text] [Related]
15. [Principles and problems of glucocorticoid therapy in ophthalmology].
Gronemeyer U
Hippokrates; 1975 Feb; 46(1):60-9. PubMed ID: 1091606
[No Abstract] [Full Text] [Related]
16. [Principles of rational therapy with external glucocorticosteroids].
Niedner R
Hautarzt; 1991 May; 42(5):337-46. PubMed ID: 1874626
[No Abstract] [Full Text] [Related]
17. [Fluocinonid--a new corticoid for the dermatologic local therapy].
Weitgasser H
Z Haut Geschlechtskr; 1972 Mar; 47(6):231-4. PubMed ID: 5019023
[No Abstract] [Full Text] [Related]
18. [Principles of topical glucocorticoid therapy in dermatology].
Haustein UF
Dermatol Monatsschr; 1985; 171(1):14-24. PubMed ID: 3979619
[No Abstract] [Full Text] [Related]
19. Corticosteroid therapy, nonendocrine disease, and corticosteroid withdrawal.
Magiakou MA; Chrousos GP
Curr Ther Endocrinol Metab; 1994; 5():120-4. PubMed ID: 7704695
[No Abstract] [Full Text] [Related]
20. [Local corticoid treatment--possibilities and recommendations].
Frosch PJ
Z Hautkr; 1987 Jun; 62(12):919-24. PubMed ID: 3617860
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
